Literature DB >> 16182408

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.

Michael I Ugwoke1, Remigius U Agu, Norbert Verbeke, Renaat Kinget.   

Abstract

Nasal drug delivery has now been recognized as a very promising route for delivery of therapeutic compounds including biopharmaceuticals. It has been demonstrated that low absorption of drugs can be countered by using absorption enhancers or increasing the drug residence time in the nasal cavity, and that some mucoadhesive polymers can serve both functions. This article reviews the background of nasal mucoadhesive drug delivery with special references to the biological and pharmaceutical considerations for nasal mucoadhesive drug administration. Applications of nasal mucoadhesives for the delivery of small organic molecules, antibiotics, proteins, vaccines and DNA are also discussed. Furthermore, new classes of functionalized mucoadhesive polymers, the characterization and safety aspects of nasal drug products as well as the opportunities presented by nasal drug delivery are extensively discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182408     DOI: 10.1016/j.addr.2005.07.009

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  70 in total

1.  Pharmacokinetic evaluation of intranasally administered vinyl polymer-coated lorazepam microparticles in rabbits.

Authors:  Yanjun Zhao; Marc B Brown; Rajeshree H Khengar; Matthew J Traynor; Pedro Barata; Stuart A Jones
Journal:  AAPS J       Date:  2012-03-01       Impact factor: 4.009

2.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

3.  Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Effects of Nasal Spray Suspension Particle Size and Properties.

Authors:  Alex Rygg; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2015-12-21       Impact factor: 4.200

Review 4.  Delivering non-hormonal contraceptives to men: advances and obstacles.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Trends Biotechnol       Date:  2008-01-11       Impact factor: 19.536

Review 5.  Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

Authors:  Thomas C Chen; Clovis O Da Fonseca; Axel H Schönthal
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

6.  Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.

Authors:  Nilesh S Saindane; Kunal P Pagar; Pradeep R Vavia
Journal:  AAPS PharmSciTech       Date:  2012-12-20       Impact factor: 3.246

7.  Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation.

Authors:  Ahmed A El-Shenawy; Reda A Mahmoud; Essam A Mahmoud; Mohamed S Mohamed
Journal:  AAPS PharmSciTech       Date:  2021-05-04       Impact factor: 3.246

8.  Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers.

Authors:  M R Lofwall; D E Moody; W B Fang; P A Nuzzo; S L Walsh
Journal:  J Clin Pharmacol       Date:  2011-05-24       Impact factor: 3.126

Review 9.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

Review 10.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Authors:  Muna Aryal; Costas D Arvanitis; Phillip M Alexander; Nathan McDannold
Journal:  Adv Drug Deliv Rev       Date:  2014-01-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.